GO:0071901 negative regulation of protein serine/threonine kinase activity: Signaling Brake, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071901 describes any biological process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity, acting as a built-in brake on phosphorylation-driven signaling.
• Key negative regulators include STK38 (NDR1), which directly phosphorylates and inhibits MEKK1/2 and PDK1, and 14-3-3 proteins, which bind and suppress PDK1 activity.
• The process is integrated with nutrient and stress sensing, for example through amino acid signaling and the integrated stress response.
• Dysregulation of these brakes is linked to cancer, metabolic disorders, and neurodegeneration, making the pathway a therapeutic target.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of negative regulators in specific cell contexts.
• EDITGENE provides end-to-end CRISPR services, including library screening and bioinformatics, to accelerate discovery in this regulatory network.
Description
Protein serine/threonine kinases are central to almost every signaling pathway, and their activity must be tightly controlled to avoid aberrant phosphorylation that drives disease. GO:0071901, negative regulation of protein serine/threonine kinase activity, captures the diverse mechanisms that put the brakes on these enzymes. This term is critical for understanding how cells maintain signaling fidelity, respond to stress, and prevent oncogenic transformation. Researchers studying this process aim to identify the negative regulators, map their upstream inputs, and determine how their loss contributes to pathologies such as cancer and metabolic disease. The regulatory logic often involves direct phosphorylation of the kinase itself, as seen when STK38 phosphorylates PDK1 at Thr354 to reduce its activity. Alternatively, adaptor proteins like 14-3-3 can bind and sequester kinases in an inactive state. Nutrient and stress signals also feed into this regulation, ensuring that kinase activity matches cellular needs. Because these brakes are frequently mutated or dysregulated in human disease, they represent attractive targets for therapeutic intervention and biomarkers. This article synthesizes the current understanding of GO:0071901, highlighting key genes, mechanisms, disease links, and the experimental models used to study it.
negative regulation of protein serine/threonine kinase activity At A Glance
| GO ID | GO:0071901 |
|---|---|
| GO term | negative regulation of protein serine/threonine kinase activity |
| Ontology | biological_process |
| Synonym | none |
| Major function | Decreases the rate, frequency, or extent of protein serine/threonine kinase activity |
| Example regulators | STK38 (NDR1), 14-3-3 proteins, PDK1 |
| Associated processes | MEKK1/2 signaling, PDK1 activity, amino acid signaling, stress response |
| Disease relevance | Cancer, metabolic disorders, neurodegeneration |
What Is GO:0071901?
GO:0071901 is defined as any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity. In other words, it encompasses all molecular events that inhibit the catalytic function of enzymes that phosphorylate serine or threonine residues on target proteins. This regulation can occur through direct modification of the kinase, binding by inhibitory partners, or changes in subcellular localization, ultimately reducing downstream phosphorylation events.
Why Is negative regulation of protein serine/threonine kinase activity Important in Cell Biology?
GO:0071901 is fundamental because it ensures that serine/threonine kinase signaling is not constitutively active. Without these negative regulators, cells would experience unchecked phosphorylation, leading to uncontrolled proliferation, impaired stress responses, and metabolic imbalance. Understanding this process provides insight into how normal cells maintain homeostasis and how disruption contributes to diseases such as cancer, where tumor suppressors that act as negative regulators are often lost.
• Prevents aberrant kinase activity that could drive oncogenesis.
• Integrates nutrient and stress signals to match kinase activity with cellular demands.
• Controls key pathways such as MEKK1/2 and PDK1, which are involved in proliferation and survival.
• Dysregulation is implicated in cancer, metabolic disorders, and neurodegeneration.
• Provides potential therapeutic targets for small-molecule inhibitors or activators.
• Essential for understanding drug resistance mechanisms in kinase-driven cancers.
• Helps explain off-target effects of kinase inhibitors.
• Guides development of biomarkers for pathway activity.
• Informs CRISPR-based functional genomics screens.
• Facilitates rational design of combination therapies.
What Happens During negative regulation of protein serine/threonine kinase activity?
Direct Phosphorylation of the Kinase
In simple terms: One kinase can add a phosphate to another kinase to turn it off.
A common mechanism is the direct phosphorylation of a serine/threonine kinase by another kinase, which reduces its catalytic activity. For example, STK38 (also known as NDR1) phosphorylates PDK1 at Thr354, leading to decreased PDK1 activity. Similarly, STK38 negatively regulates MEKK1/2 signaling by phosphorylating these kinases. This creates a negative feedback loop or a parallel inhibitory circuit that fine-tunes signaling output.
Binding by Inhibitory Proteins
In simple terms: Other proteins can grab onto a kinase and block its function.
Inhibitory proteins can bind to serine/threonine kinases and sterically hinder their activity or prevent access to substrates. The 14-3-3 family of proteins is a prime example; they bind to phosphorylated motifs on PDK1 and suppress its kinase activity. This binding can also sequester the kinase in the cytoplasm, away from its substrates, adding another layer of regulation.
Integration with Nutrient and Stress Signaling
In simple terms: The cell's nutrient and stress status can flip the switch on kinase activity.
Negative regulation of serine/threonine kinases is often coupled to environmental cues. Amino acid availability modulates signaling pathways that control kinase activity, ensuring that growth signals are only active when nutrients are sufficient. Similarly, stress-induced gene expression programs, such as the integrated stress response, involve translational control that can impact kinase levels and activity. This integration prevents wasteful or harmful phosphorylation under adverse conditions.
Regulation of p53 and Cell Cycle Checkpoints
In simple terms: Turning off certain kinases can actually activate tumor suppressors.
Negative regulation can have paradoxical effects on downstream pathways. For instance, STK38 activates p53 function through phosphorylation at Ser15, which is a positive regulatory event for p53 but may involve inhibition of other kinases that normally suppress p53. This illustrates how negative regulation of one kinase can lead to activation of a tumor suppressor, highlighting the complexity of the network.
Key Genes Involved in GO:0071901 negative regulation of protein serine/threonine kinase activity
The following genes and proteins are central to the negative regulation of protein serine/threonine kinase activity, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| STK38 | Phosphorylates and inhibits MEKK1/2 and PDK1 | Key negative regulator; linked to cancer and cell cycle control |
| PDK1 | Target of negative regulation; phosphorylates AGC kinases | Central node in PI3K/AKT signaling; inhibited by STK38 and 14-3-3 |
| MEKK1 | Mitogen-activated protein kinase kinase kinase | Involved in stress and inflammatory signaling; inhibited by STK38 |
| MEKK2 | Mitogen-activated protein kinase kinase kinase | Involved in JNK and ERK pathways; inhibited by STK38 |
| YWHAB (14-3-3 beta) | Binds and inhibits PDK1 | Adaptor protein that negatively regulates kinase activity |
| YWHAG (14-3-3 gamma) | Binds and inhibits PDK1 | Adaptor protein that negatively regulates kinase activity |
| YWHAZ (14-3-3 zeta) | Binds and inhibits PDK1 | Adaptor protein that negatively regulates kinase activity |
| ULK1 | Serine/threonine kinase regulated by phosphorylation | Target of multiple phosphorylation events; involved in autophagy |
| RACK1 | Scaffold protein phosphorylated by kinases | In plants, phosphorylation affects signaling; potential regulatory node |
| TP53 | Tumor suppressor activated by STK38 | Downstream effector of STK38-mediated signaling |
| EIF2AK1 (HRI) | Heme-regulated inhibitor kinase | Part of integrated stress response; kinase activity is regulated |
| EIF2AK2 (PKR) | Double-stranded RNA-activated kinase | Part of integrated stress response; kinase activity is regulated |
| EIF2AK3 (PERK) | ER stress kinase | Part of integrated stress response; kinase activity is regulated |
| EIF2AK4 (GCN2) | Amino acid deprivation kinase | Part of integrated stress response; kinase activity is regulated |
| PPP1CA | Protein phosphatase 1 catalytic subunit | Counteracts kinase activity by dephosphorylation; indirect negative regulator |
| PPP2CA | Protein phosphatase 2 catalytic subunit | Counteracts kinase activity by dephosphorylation; indirect negative regulator |
| PPM1A | Protein phosphatase 2C | Dephosphorylates and inactivates kinases; indirect negative regulator |
| PPM1B | Protein phosphatase 2C | Dephosphorylates and inactivates kinases; indirect negative regulator |
How Is negative regulation of protein serine/threonine kinase activity Regulated?
The negative regulation of protein serine/threonine kinase activity is itself subject to regulation by upstream signals. For example, STK38 activity can be modulated by phosphorylation and binding partners, which in turn affects its ability to inhibit MEKK1/2 and PDK1. The 14-3-3 proteins are regulated by phosphorylation and dimerization, influencing their binding to PDK1. Nutrient signaling pathways, such as those involving amino acids, can alter the expression or activity of negative regulators to match cellular growth demands. Additionally, stress-responsive kinases like ULK1 are controlled by multiple phosphorylation events that can either activate or inhibit their function, indirectly affecting the negative regulation of other kinases. The integrated stress response, mediated by eIF2α kinases, also intersects with these regulatory networks.
negative regulation of protein serine/threonine kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| STK38 | Cancer (various solid tumors) | Knockout and overexpression in cancer cell lines; xenograft models |
| PDK1 | Cancer, metabolic disorders | Point mutation at Thr354 to prevent STK38 phosphorylation; knock-in mice |
| MEKK1 | Inflammatory diseases, cancer | Knockout mice; kinase-dead knock-in |
| TP53 | Cancer (Li-Fraumeni syndrome) | Knock-in of phospho-mimetic Ser15 to study STK38-p53 axis |
| 14-3-3 (YWHAZ) | Cancer, neurological disorders | Knockout and knock-in of binding-deficient mutants |
Cancer
Loss of negative regulation of serine/threonine kinases can lead to hyperactive signaling that promotes tumorigenesis. STK38, a key negative regulator, is downregulated in some cancers, and its ability to inhibit MEKK1/2 and PDK1 suggests that its loss could enhance proliferative and survival signals. Furthermore, STK38 activates p53, so its impairment may compromise p53-mediated tumor suppression. Targeting the pathways that restore negative regulation is a potential therapeutic strategy.
Metabolic Disorders
Nutrient signaling pathways that control kinase activity are often dysregulated in metabolic diseases such as diabetes and obesity. Amino acid sensing pathways that impinge on serine/threonine kinases can contribute to insulin resistance and altered glucose metabolism. Negative regulators like STK38 may play a role in integrating nutrient status with metabolic outputs, and their dysfunction could exacerbate metabolic imbalance.
Neurodegeneration
Dysregulated kinase activity is a hallmark of neurodegenerative diseases, where aberrant phosphorylation of proteins like tau contributes to pathology. Negative regulators that keep kinases in check may be protective, and their failure could accelerate neurodegeneration. The integrated stress response, which involves kinase regulation, is also implicated in neuronal survival.
From negative regulation of protein serine/threonine kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does STK38 negatively regulate PDK1 in vivo? | Stk38 knockout mouse; PDK1 activity assays in tissues |
| What is the effect of constitutive PDK1 activation? | PDK1 T354A knock-in mouse (phospho-deficient) |
| How does 14-3-3 binding affect PDK1 localization? | Ywhaz knockout cells; immunofluorescence and fractionation |
| Can STK38 overexpression suppress tumor growth? | Xenograft models with STK38 overexpression |
| What are the downstream targets of MEKK1/2 inhibition? | MEKK1/2 knockout cells; phosphoproteomics |
| Does p53 Ser15 phosphorylation mediate STK38 tumor suppression? | p53 S15A knock-in mouse; cancer models |
How to Study the negative regulation of protein serine/threonine kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Phosphoproteomics | Global phosphorylation changes | Identify substrates of negative regulators |
| In vitro kinase assay | Direct kinase activity | Test inhibitory effect of a protein on a kinase |
| CRISPR knockout screen | Gene essentiality or reporter activity | Discover novel negative regulators |
| FRET biosensor imaging | Real-time kinase activity | Study spatiotemporal regulation |
| Co-immunoprecipitation | Protein-protein interactions | Detect binding of inhibitors like 14-3-3 |
| Western blot | Phosphorylation status of specific sites | Validate kinase inhibition |
| qPCR | mRNA expression levels | Assess transcriptional regulation of negative regulators |
Phosphoproteomics
Mass spectrometry-based phosphoproteomics allows global identification of phosphorylation events regulated by negative regulators. By comparing wild-type and knockout cells, one can map the substrates and downstream effects of kinases like STK38 and PDK1.
Kinase Activity Assays
In vitro kinase assays using recombinant proteins or immunoprecipitated kinases measure the direct effect of negative regulators. For example, incubating PDK1 with STK38 and ATP can show reduced PDK1 autophosphorylation or substrate phosphorylation.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify genes that negatively regulate a specific kinase activity reporter. This approach is powerful for discovering novel regulators and pathways.
Imaging and FRET Biosensors
Genetically encoded FRET biosensors can monitor kinase activity in live cells with spatiotemporal resolution. These tools can visualize how negative regulators affect kinase dynamics in response to stimuli.
How CRISPR Can Be Used to Study GO:0071901 negative regulation of protein serine/threonine kinase activity
Knockout
CRISPR knockout of a negative regulator such as STK38 can lead to hyperactivation of its target kinases, providing a clean system to study downstream effects. For example, STK38 knockout cells show increased MEKK1/2 and PDK1 activity, which can be assessed by phospho-specific antibodies.
Point Mutation
Introducing point mutations that abolish phosphorylation sites, such as PDK1 T354A, can prevent negative regulation and create a constitutively active kinase. This allows researchers to dissect the specific contribution of a single phosphorylation event to kinase regulation.
Knock-in
Knock-in of tagged or mutant versions of negative regulators, such as a phospho-mimetic STK38, can help visualize localization and interactions. Tagged knock-in of 14-3-3 proteins can reveal binding dynamics with PDK1.
Overexpression
Overexpression of a negative regulator like STK38 can suppress target kinase activity and downstream signaling, offering a gain-of-function approach to study pathway inhibition. This is useful for validating tumor suppressor functions.
How EDITGENE Supports negative regulation of protein serine/threonine kinase activity Research
Researchers studying negative regulation of protein serine/threonine kinase activity-related genes often need to determine whether a candidate gene is causally involved in the regulatory process. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of protein serine/threonine kinase activity research.
Frequently Asked Questions About negative regulation of protein serine/threonine kinase activity
What is negative regulation of protein serine/threonine kinase activity?
It is any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity, as defined by GO:0071901.
What genes are involved in negative regulation of protein serine/threonine kinase activity?
Key genes include STK38, PDK1, MEKK1, MEKK2, and 14-3-3 family members such as YWHAB, YWHAG, and YWHAZ.
How does STK38 negatively regulate kinase activity?
STK38 phosphorylates target kinases like PDK1 at Thr354 and MEKK1/2, leading to reduced activity.
What is the role of 14-3-3 proteins in kinase regulation?
14-3-3 proteins bind to phosphorylated motifs on kinases such as PDK1, inhibiting their activity and altering localization.
Which diseases are linked to dysregulated negative regulation of serine/threonine kinases?
Cancer, metabolic disorders, and neurodegeneration have been associated with impaired negative regulation.
How can CRISPR be used to study negative regulation of kinase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of negative regulators to assess their impact on kinase activity.
What methods are used to measure negative regulation of kinase activity?
Phosphoproteomics, in vitro kinase assays, FRET biosensors, and Western blotting are commonly used.
Is negative regulation of protein serine/threonine kinase activity a biological process?
Yes, it is a biological process ontology term (GO:0071901).
What is the definition of GO:0071901?
Any process that decreases the rate, frequency, or extent of protein serine/threonine kinase activity.
How does nutrient signaling affect negative regulation of kinases?
Amino acid availability can modulate pathways that control kinase activity, ensuring growth signals are active only when nutrients are sufficient.
Conclusion
GO:0071901, negative regulation of protein serine/threonine kinase activity, is a critical biological process that maintains signaling homeostasis. The interplay between kinases like STK38, PDK1, and MEKK1/2, along with adaptor proteins such as 14-3-3, illustrates the complexity of these brakes. Dysregulation of this process contributes to cancer, metabolic disorders, and neurodegeneration, making it a rich area for therapeutic targeting. Advances in CRISPR technology and functional genomics are poised to uncover new regulators and mechanisms, offering hope for novel interventions.
References
- 1. Harding HP et al.. 2000. Regulated translation initiation controls stress-induced gene expression in mammalian cells.. Mol Cell 6(5):1099-108 PMID: 11106749
- 2. Enomoto A et al.. 2008. Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38 (STK38).. Oncogene 27(13):1930-8 PMID: 17906693
- 3. Chen JG. 2015. Phosphorylation of RACK1 in plants.. Plant Signal Behav 10(8):e1022013 PMID: 26322575
- 4. Sato S et al.. 2002. Regulation of kinase activity of 3-phosphoinositide-dependent protein kinase-1 by binding to 14-3-3.. J Biol Chem 277(42):39360-7 PMID: 12177059
- 5. Seong HA et al.. 2012. PDK1 protein phosphorylation at Thr354 by murine protein serine-threonine kinase 38 contributes to negative regulation of PDK1 protein activity.. J Biol Chem 287(25):20811-22 PMID: 22544756
- 6. Yan L et al.. 2011. Signalling by amino acid nutrients.. Biochem Soc Trans 39(2):443-5 PMID: 21428916
- 7. Bach M et al.. 2011. The serine/threonine kinase ULK1 is a target of multiple phosphorylation events.. Biochem J 440(2):283-91 PMID: 21819378
- 8. Seong HA et al.. 2012. Murine protein serine-threonine kinase 38 activates p53 function through Ser15 phosphorylation.. J Biol Chem 287(25):20797-810 PMID: 22532570
